D.A. Davidson & CO. trimmed its holdings in athenahealth, Inc. (NASDAQ:ATHN) by 0.7% in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 1,557 shares of the health services provider’s stock after selling 11 shares during the quarter. D.A. Davidson & CO.’s holdings in athenahealth were worth $218,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds have also bought and sold shares of the company. Morgan Stanley boosted its position in shares of athenahealth by 9.7% in the first quarter. Morgan Stanley now owns 4,514,305 shares of the health services provider’s stock valued at $508,717,000 after acquiring an additional 397,837 shares during the period. Vanguard Group Inc. boosted its position in shares of athenahealth by 4.5% in the first quarter. Vanguard Group Inc. now owns 3,047,282 shares of the health services provider’s stock valued at $343,399,000 after acquiring an additional 130,569 shares during the period. BlackRock Inc. boosted its position in shares of athenahealth by 2.0% in the second quarter. BlackRock Inc. now owns 1,631,993 shares of the health services provider’s stock valued at $229,377,000 after acquiring an additional 32,146 shares during the period. Clearbridge Investments LLC boosted its position in shares of athenahealth by 61.8% in the first quarter. Clearbridge Investments LLC now owns 908,505 shares of the health services provider’s stock valued at $102,379,000 after acquiring an additional 347,133 shares during the period. Finally, State Street Corp boosted its position in shares of athenahealth by 3.7% in the first quarter. State Street Corp now owns 502,823 shares of the health services provider’s stock valued at $56,662,000 after acquiring an additional 17,718 shares during the period.

TRADEMARK VIOLATION NOTICE: This report was originally published by Watch List News and is the sole property of of Watch List News. If you are accessing this report on another publication, it was stolen and republished in violation of United States & international copyright & trademark laws. The original version of this report can be viewed at https://www.watchlistnews.com/d-a-davidson-co-trims-stake-in-athenahealth-inc-athn/1612136.html.

Shares of athenahealth, Inc. (NASDAQ:ATHN) opened at 122.11 on Friday. athenahealth, Inc. has a 12 month low of $90.11 and a 12 month high of $158.66. The firm has a market capitalization of $4.88 billion, a price-to-earnings ratio of 154.96 and a beta of 1.76. The company has a 50-day moving average price of $131.53 and a 200-day moving average price of $129.63.

athenahealth (NASDAQ:ATHN) last issued its earnings results on Thursday, July 20th. The health services provider reported $0.51 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.39 by $0.12. athenahealth had a return on equity of 6.91% and a net margin of 2.80%. The business had revenue of $301.10 million during the quarter, compared to analysts’ expectations of $298.68 million. During the same quarter in the prior year, the firm earned $0.34 EPS. The business’s revenue for the quarter was up 15.0% compared to the same quarter last year. Equities analysts forecast that athenahealth, Inc. will post $1.91 EPS for the current fiscal year.

In other athenahealth news, insider Daniel P. Haley sold 1,583 shares of the company’s stock in a transaction dated Monday, October 2nd. The stock was sold at an average price of $124.56, for a total value of $197,178.48. Following the completion of the transaction, the insider now owns 13,408 shares of the company’s stock, valued at approximately $1,670,100.48. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, CEO Jonathan Bush sold 4,000 shares of the company’s stock in a transaction dated Monday, October 2nd. The stock was sold at an average price of $124.17, for a total value of $496,680.00. Following the completion of the transaction, the chief executive officer now directly owns 319,807 shares of the company’s stock, valued at approximately $39,710,435.19. The disclosure for this sale can be found here. In the last ninety days, insiders sold 16,505 shares of company stock valued at $2,240,851. Insiders own 3.20% of the company’s stock.

Several research firms have recently weighed in on ATHN. Piper Jaffray Companies reissued a “buy” rating and issued a $152.00 price objective on shares of athenahealth in a research report on Friday, July 14th. Oppenheimer Holdings, Inc. increased their price objective on athenahealth from $154.00 to $184.00 and gave the company an “outperform” rating in a research report on Friday, July 21st. Wells Fargo & Company reissued an “outperform” rating and issued a $190.00 price objective (up from $130.00) on shares of athenahealth in a research report on Saturday, July 22nd. BidaskClub cut athenahealth from a “hold” rating to a “sell” rating in a research report on Tuesday, August 1st. Finally, Citigroup Inc. reissued a “buy” rating and issued a $169.00 price objective (up from $163.00) on shares of athenahealth in a research report on Monday, July 10th. Three research analysts have rated the stock with a sell rating, twelve have issued a hold rating and twelve have issued a buy rating to the company. The company has an average rating of “Hold” and a consensus target price of $149.91.

athenahealth Profile

athenahealth, Inc provides network-based medical record, revenue cycle, patient engagement, care coordination and population health services. The Company also offers Epocrates and other point-of-care mobile applications. The Company delivers majority of its service offerings through a single instance of cloud-based software, athenaNet.

Institutional Ownership by Quarter for athenahealth (NASDAQ:ATHN)

Receive News & Ratings for athenahealth Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for athenahealth Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.